Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflexal V Dosing Comparison in Children
NCT01229397Phase 3Completed
- Sponsor
- Crucell
- Start
- Oct 2010
- Primary completion
- Nov 2010
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Inflexal V in influenza, sponsored by Crucell. Started Oct 2010; status: completed.
02
Drugs
Inflexal V
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01229397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01229397.